Table 2 Demographic data of patients with different causes of CHF
CHD | HBP | CHD+HBP | DCM | P * | |
|---|---|---|---|---|---|
n = 103 | n = 39 | n = 35 | n = 14 | ||
Age (years) | 66.30 ± 5.99 | 64.77 ± 6.31 | 68.03 ± 5.51 | 66.93 ± 4.12 | 0.12 |
Male (%) | 63 (61.17%) | 20 (51.28%) | 21 (60.00%) | 5 (36%) | 0.27 |
HR (beat/min) | 70.78 ± 16.89 | 73.26 ± 15.89 | 72.97 ± 16.92 | 77.5 ± 20.19 | 0.51 |
SBP (mmHg) | 117.40 ± 21.09 | 149.71 ± 10.67 | 144.94 ± 12.19 | 100.86 ± 3.10 | <0.01 |
DBP (mmHg) | 64.99 ± 14.36 | 84.69 ± 12.02 | 79.23 ± 12.80 | 58.14 ± 6.86 | <0.01 |
NYHA III/IV | 43/60 | 13/26 | 17/18 | 5/9 | 0.58 |
Echocardiographic data | |||||
LVEF (%) | 28.42 ± 4.04 | 27.48 ± 3.74 | 27.89 ± 4.11 | 28.47 ± 3.22 | 0.08 |
LVEDD (mm) | 58.52 ± 6.40 | 59.53 ± 5.42 | 59.07 ± 5.82 | 61.32 ± 6.04 | 0.36 |
LVESD (mm) | 37.53 ± 4.30 | 38.03 ± 3.94 | 37.88 ± 4.14 | 38.48 ± 4.49 | 0.60 |
Chemical markers | |||||
serum creatinine (μmol/l) | 126.70 ± 80.40 | 133.17 ± 93.37 | 137.06 ± 82.00 | 135.70 ± 101.50 | 0.92 |
NT-proBNP (ρg/ml) | 5281.94 (239.83-19199.74) | 5029.96 (187.21-15635.25) | 6914.30 (687.84-15716.93) | 5894.20 (1479.39-11550.13) | 0.34 |
eSOD (U/mg Hb) | 2.35 ± 1.10 | 2.22 ± 1.12 | 2.18 ± 1.24 | 2.04 ± 0.89 | 0.71 |
MDA (nmol/l) | 4.90 ± 1.97 | 4.55 ± 1.93 | 4.15 ± 2.06 | 4.85 ± 1.79 | 0.25 |
Medications at arrival | |||||
ACEIs/ARBs (%) | 25 (24.27) | 9 (23.08) | 9 (25.71) | 4 (28.57) | 0.06 |
βRB (%) | 10 (9.71) | 8 (20.51) | 9 (17.14) | 1 (7.14) | 0.08 |
Statins (%) | 28 (27.18) | 1 (2.56) | 9 (25.71) | 0 (0) | <0.01 |
Diuretics (%) | 21 (20.29) | 13 (33.33) | 10 (28.57) | 5 (35.71) | 0.31 |
Digitalis (%) | 25 (24.27) | 12 (30.77) | 10 (28.57) | 2 (14.29) | 0.61 |